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Abstract 
Background: The World Health Organization (WHO) has recommended the integration of malaria microscopy quality assessment (QA) with 
that of other microscopically diagnosed diseases, but there is no evidence that it has been attempted. We assessed the feasibility of linking 
malaria microscopy into the existing tuberculosis (TB) microscopy QA system in Kano, Nigeria. 
Methodology: Five TB microscopy centres were selected for implementing the integrated TB and malaria microscopy QA scheme in the 
state. A model system was designed for selecting and blinded rechecking of TB and malaria slides from these laboratories. Supervision and 
evaluation was conducted at 3-month intervals for 24 months.  
Results: TB microscopy QA was strengthened in four laboratories. Full integration of the QA for TB and malaria microscopy was achieved 
in two laboratories, and partial integration in two other laboratories. The programme resulted in an increase in the specificity of both TB and 
malaria microscopy results. At the final assessment, 100% specificity was achieved for TB microscopy results in four laboratories. There was 
an increased concordance rate and decreased false positivity and false negativity rates of TB microscopy results in all five laboratories. 
Conclusions: It is feasible to integrate the QA system and training for TB and malaria microscopy for assessing and improving quality of 
both services. However, the integrated system needs testing in different settings in order to be able to develop sound recommendations to 
guide the complex scaling-up process. 
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Introduction 
Kano State is one of the 36 states of Nigeria, 
located in the northern part of the country. It has an 
estimated population of over 12 million people of which 
75% live in the rural areas [1]. Tuberculosis (TB) and 
malaria are endemic in Nigeria and among the most 
important public health burdens of the country. Each 
year in Nigeria, 220,000 positive cases of pulmonary 
tuberculosis cases occur of which approximately 50% 
are smear-positive. The country was ranked fourth 
among the 22 countries with the highest burden of TB 
[2]. In Kano State, there were 5,179 registered cases of 
tuberculosis at end the of 2006, representing about 30% 
of the estimated number of TB cases in the state. There 
were 2,608,479 reported cases and 5,343 deaths due to 
malaria in Nigeria in 2003 [3]. There were 264,481 
reported cases of malaria in Kano State in the year 
2003, with prevalence of 22 per 1000 population [4]. 
Sputum smear microscopy for detecting acid-fast 
bacilli (AFB) and blood film microscopy for detecting 
parasites are important laboratory procedures for 
diagnosis and management of TB and malaria 
respectively. In order to achieve the required quality in 
laboratory diagnosis, a continuous system of quality 
assessment (QA) needs to be established [5,6]. The 
laboratory QA schemes used in industrialized countries 
are based on the assumption that the laboratory methods 
are generally automated and communication and 
transport systems are reliable, and are therefore not 
suitable for laboratories in low-income countries [7].  
In Kano there was a network of ten designated TB 
microscopy laboratories supporting the Directly 
Observed Treatment Short Courses (DOTS) in the year 
2005, and a quality assessment scheme for TB 
microscopy. There was no network of malaria 
microscopy laboratories or quality assessment scheme 
for malaria microscopy at any level of health care in the 
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state. In contrast to the situation for TB, the national 
policy for malaria does not include any QA guideline 
for microscopy [8]. The WHO has recommended the 
integration of malaria microscopy QA with that of other 
microscopically diagnosed communicable diseases [9], 
but there is no evidence for how this can be put into 
practice. 
We conducted a baseline assessment of medical 
laboratory services in Kano State and designed, 
implemented and evaluated an integrated system for 
measuring and improving quality of TB and malaria 
microscopy. 
 
Materials and Methods 
Baseline assessment of medical laboratory services for 
TB and malaria in Kano state 
The design of a QA system for TB and malaria 
microscopy requires retrospective information on the 
infrastructure, workload and slide positivity rates for 
TB and malaria microscopy. A checklist for laboratory 
assessment was developed using published guidelines 
[10,11] and checklists used in other West African 
countries [12]. Information on staffing and the number 
of TB and malaria tests conducted were collected from 
13 of the 34 medical laboratories in Kano state. 
The 13 selected laboratories included laboratories in 
the the following three largest specialist hospitals in 
urban Kano, where laboratory services are concentrated: 
Murtala Muhammad Specialist hospital (MMSH), 
Muhammad Abdullahi Wase Specialist Hospital 
(MAWSH), and Hasiya Bayero Paediatric Hospital 
(HBP). The following ten designated DOTS microscopy 
centres located in urban and semi-urban areas were also 
included  in  the study: the Infectious Disease Hospital 
(IDH), Wudil General Hospital (WDL) Gezawa General 
Hospital (GZW) Gwarzo General Hospital (GWZ), 
Danbatta General Hospital (DBT), Kura General 
Hospital (KUR), Bichi General Hospital (BCH) Rano 
General Hospital (RAN), Sumaila General Hospital 
(SML), and Karaye General Hospital (KRY). The 
selected laboratories were representative laboratories 
where laboratory services in Kano state are likely 
reflected.  
Five out of the 10 designated microscopy centres 
(IDH, WDL, GWZ, RAN and DBT) where TB 
microscopy slides were stored were selected for 
implementing the integrated TB and malaria 
microscopy QA scheme. Examined TB slides were 
sampled from the five DOTS microscopy centres. 
Malaria slides were from only two of the five centres 
(IDH and WDL) where malaria slides were available 
during the assessment period.  
 
Method of sampling slides 
The Lot Quality Assurance System (LQAS) 
sampling method (APHL, 2002) was used for selecting 
the examined TB and malaria microscopy slides. LQAS 
sampling determines an optimum sample size that 
yields a statistically acceptable sample to assess quality 
of work, in this case TB and malaria microscopy [13,9]. 
The numbers of TB and malaria slides selected were 
determined using the Lot number, which is the average 
number of negative TB or malaria slides examined by a 
laboratory in three-month period (quarter). A standard 
reference table of sample sizes set at a critical value of 
5%, sensitivity of 80%, specificity of 100%, acceptance 
number d=0 and 95% Confidence Interval was used to 
determine the number of TB and malaria slides required 
from each laboratory for rechecking per each quarter 
[11]. Thus 17 TB slides were required quarterly from 
each laboratory based on an annual average of 5,000 
negative smears per laboratory, with a positivity rate of 
15%. Eight malaria slides were required quarterly from 
each laboratory based on an annual average of 2000 
negative slides per laboratory and a slide positivity rate 
of 47.2%.  
Sampling intervals were determined by dividing the 
total number of slides examined in the quarter by 17 
and eight for TB and malaria slides respectively. The 
resulting number (N) was the interval between each of 
the slides to be selected. In order to eliminate selection 
bias, slides were selected by the supervisor from the 
entire lot using the laboratory register irrespective of 
whether the result was positive or negative and 
regardless of the quality of the smear or staining. The 
selected slides were retrieved from the slide boxes with 
the help of the microscopists in the laboratory. If a slide 
was missing, it was substituted by the one after it. When 
several slides were missing, the selection was repeated 
from the register starting from a different point. 
 
Design and implementation of integrated TB and 
malaria microscopy QA scheme 
A group of five experienced TB and malaria 
microscopists were selected from the tertiary and 
secondary healthcare facilities in Kano to collaborate on 
the project. A one-day refresher training workshop on 
the identification of AFB in ZN-stained sputum smear 
and malaria parasites in Leishman-stained thin blood 
film was conducted for the QA team together with the 
microscopists from the five selected centres. The 
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purpose of the training was to demonstrate the degree of 
accord and discord between the original results of 
malaria parasites microscopy from the source centres 
and the results obtained from the rechecking process by 
the participants, and to develop an integrated, feasible 
method for assessment of the quality of TB and malaria 
smear / blood films staining. The training involved 
group rechecking and evaluation of TB slides and 
malaria slides from participating centres, and 
examination and reporting of positive and negative 
control TB and malaria slides.  
Community tuberculosis control supervisors from 
the five selected centres were also trained on how to 
incorporate supervision of malaria microscopy and slide 
selection for quality assessment into the TB quality 
assessment scheme. 
TB and malaria microscopy slides were collected 
by the TB supervisor and submitted to the state TB 
quality control officer at three-month intervals for re-
checking at a state secondary laboratory. The slides 
were rechecked independently by two of the five 
selected microscopists. TB and malaria microscopy 
checks were integrated by using a pair of microscopists 
from the pool of five experienced microscopists with 
skills in both malaria and TB microscopy. Although the 
scheme focused on QA, the quality control culture in 
these laboratories was assessed by the availability of 
microscopists during supervisory visits and their ability 
to make available all the TB and malaria slides 
examined in their laboratories (Figure 1).  
 
Protocol for re-checking of TB and malaria slides 
The first reader re-examined the sampled slides 
visually to assess the quality of smear and blood film 
preparation as good, fair or bad using predefined criteria 
(Table 1). One hundred high-power fields were 
examined for negative. Results from TB slides were 
graded using the standard grading table for TB 
microscopy [14]. Results of malaria microscopy were 
recorded as positive Plasmodium falciparum if 
trophozoites were present at < 10/field and >10/field, or 
negative to indicate their absence [9]. 
The quality control officer compared the first 
reader’s result with those of the original reader. If the 
original and first reader results agreed, the original was 
accepted. Slides with discordant results were counter-
checked by the second reader without knowing the 
results of the first reader. The final result was taken as 
any two consensus results among the three readings. 
Errors in reading TB and malaria microscopy slides 
were classified as: 
 False positives (FP), when a negative sputum 
smear or  blood film was misread positive 
 False negatives (FN), when a positive sputum 
smear or blood film was misread as negative. 
 
Table 1. Criteria for assessing the quality of TB and malaria 
slides. 
 
Quality of preparation and staining of sputum smear and 
blood films for TB and malaria microscopy 
Grades Sputum smear / staining* 
Good Smear of approximately 1 x 2 cm, evenly distributed on the 
glass slide; thickness allows printed letters to be read through. 
Staining allows AFB and the background to be clearly 
distinguished as red against a bluish background.  
Fair Smear is thick so that printed letter cannot be read through or 
unevenly distributed with a size more than 1x 2 cm. 
Staining: Due to over decolourization, AFB appears faint red 
colour or due to under decolourization remnants of carbol 
fuchsin or methylene blue appear on the background or 
unsmeared parts of the slide. 
Bad Smear is made from saliva and was too thin with indefinite 
size or made too thick so that printed letters cannot be read 
through. 
Stains stick on the smear and fields difficult to spot with AFB 
or  
Smear was made from saliva and cannot pick up the stain. 
Grades Thin blood film / Leishman staining** 
Good Gross appearance: A thin film with distinct head, body and 
tail. 
Microscopic appearance: Demonstrates a monolayer of 
RBCs, and RBCs with normal and abnormal morphology.  
Staining allows the trophozoits, gametocytes and /or schizonts 
and the white blood cells to be clearly distinguished against 
the background. 
Fair Gross appearance: Film with uneven tail, too thick, too wide 
or too long with uneven thickness. 
Microscopic appearance: Demonstrates a monolayer of 
RBCs, fixed RBCs and RBCs with abnormal morphology.  
Staining allows the trophozoits, gametocytes and /or schizonts 
malaria parasites and the white blood cells to be clearly 
distinguished against the background. 
Bad Gross appearance: Film with ragged tail, too thick, too wide 
or too long with uneven thickness. 
Microscopic appearance: Distorted appearance of the RBCs, 
malaria parasite and the white cells. 
 Difficult to spot fields with monolayer of cells and distorted 
appearance of the RBCs, malaria parasite and the white cells. 
* Technical guide for Sputum Examination for Tuberculosis by Direct Microscopy in 
Low Income Countries [14]. RBC = Red blood cells 
 
The assessments of quality of TB and malaria 
microscopy used were 1) the proportions of original 
microscopy results that were concordant, false positive 
or false negative; 2) the proportions of well prepared 
and / or stained sputum smears and blood films; 3) the 
sensitivity defined as the ability of microscopists in the 
study laboratories to detect AFB or malaria parasites 
relative to the final results, and specificity defined as 
the ability of microscopists in the study laboratories to 
identify AFB or malaria parasites correctly when 
Sarkinfada et al. – Quality assessment for TB and malaria microscopy 
 23 
 
J Infect Developing Countries 2009; 3(1): 20-27. 
present in sputum smears or blood films. Trends in the 
 
Figure 1. An integrated QA scheme for TB and malaria 
microscopy. 
 
Key: AFB = TB microscopy                 MP = Malaria microscopy. 
 
changes of quality assessment and comparison of the 
baseline and final performance of each laboratory were 
evaluated. 
 
Evaluation of integration 
Full integration of TB and malaria EQA in 
laboratories was defined as the three assessments for 
malaria microscopy that were conducted during the TB 
microscopy supervisory visits. Partial integration was 
defined as at least one joint assessment and no 
integration was where malaria microscopy assessment 
was not conducted.  
SPSS 15.0 software was used to determine the 
statistical significance of the changes observed between 
the periods of assessment using the Chi square test of 
significance. Kappa statistics were used to determine 
the coefficient of agreement (Kappa) between results 
from the district laboratories and the first and second re-
readings, using the Win Episcope version 2.0 
programme. Correlation coefficients between the 
numbers of concordant results and the numbers of good, 
fair and bad sputum smears and/or blood films and 
staining were determined using the SPSS programme.  
 
Results 
Baseline assessment of TB and malaria laboratory 
services in Kano State (April 2005) 
The profiles of laboratories included in the baseline 
assessment are presented in Table 2. Microscopy tests 
made up 21% of the tests conducted in one year. The 
proportions of malaria and AFB microscopy among the 
microscopy tests were 35.1% and 27.2% respectively. 
The highest numbers of TB and malaria microscopy 
tests in Kano were conducted in IDH and MMSH 
laboratories respectively. 
The five laboratories selected for implementing TB 
and malaria microscopy quality assessments had at least 
one microscope and two microscopists covering both 
TB and malaria. TB microscopy was concentrated at 
IDH, where 12,525 TB slides were examined in 2004, 
constituting more than 70% of all the TB microscopy 
slides examined in the same year. The number of TB  
 
Table 2. Profiles of thirteen medical laboratories in Kano 
state. 
 
Infrastructure and workload 
Levels of 
care 
Laboratories 
Number of 
rooms 
Number 
of staff 
Number of 
tests 
conducted in 
2004 
Number 
of 
microsco
pes 
Tertiary  
MMSH 7 60 196392 3 
MAWSH 5 17 49159 3 
Secondary 
HBP 2 8 4821 2 
IDH* 2 6 19244 1 
WDL* 1 5 25481 1 
GZW* 1 3 7454 1 
GWZ* 1 5 5465 1 
DBT* 1 6 16768 1 
KUR* 1 5 7086 1 
BCH* 1 5 5202 1 
RAN* 1 4 8975 1 
SML* 1 3 3426 - 
KRY* 1 1 264 - 
Total 13  128 287786 16 
Levels of 
care 
Number of 
TB/malaria 
microscopists 
Number of 
TB 
microscopy 
tests  in 2004 
TB slide 
positivity 
rate (%) 
Number of 
malaria 
microscopy 
tests in 2004 
Malaria 
slide 
positivity 
rate (%) 
Tertiary  
2 1800 ND 8700 51 
2 80 ND 3251 23.4 
Secondary 
2 - ND 566 83.3 
2 12525 15 1109 84.2 
2 790 15 2016 38.9 
1 - ND 1448 ND 
2 349 14 953 ND 
1 508 11 2350 ND 
2 - ND - ND 
2 37 ND 205 ND 
2 320 22 476 ND 
1 - ND - ND 
1 - ND 
- 
 
ND 
Total 22 16329  21074  
*Designated AFB microscopy centres. – None. ND = Not Determined. 
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slides examined in the other four laboratories ranged 
from 37 in BCH to 1800 in MMSH. The TB slide 
positivity rates in these laboratories ranged from 11% to 
22%.  
Malaria microscopy workload was highest in 
MMSH and MAWSH laboratories, which examined 
8,700 and 3251 malaria slides respectively in 2004. 
Malaria slides examined in MMSH constituted more 
than 40% of malaria slides examined in all the 
laboratories included in this assessment. The number of 
malaria slides examined in the other laboratories ranged 
from 205 in SML to 2,016 in WDL laboratories. The 
malaria slide positivity rates ranged from 23.4% to 
84.2%. 
 
Implementation of integrated TB and malaria 
microscopy QA scheme (2005-2007) 
Integrating TB and malaria microscopy EQA scheme 
The training workshop introduced participants to 
the principles and practice of quality assessments for 
TB and malaria and the feasibility of developing an 
integrated system for assessment of TB and malaria 
slides. However, evaluation of the impact of the training 
was not feasible. The integrated TB-malaria QA scheme 
was fully or partially achieved in four of the five 
laboratories. Full integration of QA was achieved in two 
laboratories (IDH and WDL), where microscopists were 
able to make available all the TB and malaria slides 
examined in their laboratories during supervisory visits. 
Partial integration was achieved in two other 
laboratories (GWZ and DBT) where microscopists did 
not store malaria slides during the baseline assessment 
period.  
 
Assessment of the quality of TB and malaria 
microscopy results 
TB slides were assessed on six occasions, while 
malaria slides were assessed on three occasions. Results 
of the baseline quality of TB microscopy from the five 
laboratories compared with results of the final 
assessment at 24 months showed that the concordance 
rate increased from 81.0% (K = 0.353) to 91.0%  (K = 
0.792). The concordance rate had a positive correlation 
with well-made sputum smears (r = 0.539) and staining 
(r= 0.963) (Table 2). Concordance rate of malaria 
microscopy from IDH and WDL, where full integration 
was achieved, increased from 69.2% at the baseline (K 
=0.435), to 83.3% at the final assessment (K =0.667) in 
IDH and decreased from 100% to 83.3% in WDL. 
There was a similar positive correlation of concordant 
malaria microscopy results with well-made blood films 
(r = 0.908) and good staining (r = 0.963). 
The proportion of false positive TB microscopy 
readings from all five laboratories combined decreased 
significantly (χ2 = 59.8, P < 0.001) from 19.0% at the 
baseline to 1.8% at the final assessment. The false 
positivite rates of TB microscopy results decreased in 
four of the laboratories. There was also a decrease in the 
false positivite rate of malaria microscopy in IDH from 
30.8% at the baseline to 0% at the final assessment. The 
false negative rate increased from 0% at the baseline to 
3.6% at the final assessment due to the appearance of 
false negative results from IDH and DBT laboratories at 
the final assessment (Table 3).   
 
Table 3. Results of LQAS and blinded rechecking of TB and 
malaria microscopy slides from five laboratories in Kano 
(2005 – 2006). 
Quality assessments TB microscopy 
Laboratories 
Indices of 
assessment N
S
 
G
S
M
 (
%
) 
G
S
T
 (
%
) 
C
O
N
 (
%
) 
F
P
 (
%
) 
F
N
 (
%
) 
S
E
N
 (
%
) 
S
P
E
 (
%
) 
IDH 
Baseline 28 50 67.9 78.6 21.4 0 100 76 
Final 15 46.7 40 86.7 0 6.7 66.7 100 
WDL 
Baseline 11 36.4 72.7 72.7 27.3 0 100 66.7 
Final 15 73.3 80 93.3 0 0 100 100 
GWZ 
Baseline 22 40.9 45.5 95.5 4.5 0 - - 
Final 14 64.3 71.4 100 0 0 100 100 
DBT 
Baseline 27 18.5 22.2 96.6 3.7 0 100 96 
Final 12 41.7 41.7 83.3 8.3 8.3 50 90 
RAN 
Baseline 12 50 41.7 33.3 66.6 0 - - 
Final NA NA NA NA NA NA NA NA 
All centres 
combined 
Baseline 100 38 48 81 19 0 100 80 
Final 56 57.1 58.9 91.1 1.8 3.6 77.8 97.9 
Quality assessments Malaria microscopy 
Laboratories 
Indices of 
assessment N
S
 
G
B
F
 (
%
) 
G
S
T
 (
%
) 
C
O
N
 (
%
) 
F
P
 (
%
) 
F
N
 (
%
) 
S
E
N
 (
%
) 
S
P
E
 (
%
) 
IDH 
Baseline 13 46.2 69.2 69.2 30.8 0 100 55.6 
Final 6 50 50 83.3 0 16.7 75 100 
WDL 
Baseline 13 61.5 84.6 100 0 0 100 100 
Final 6 83.3 83.3 83.3 16.7 0 66.7 100 
GWZ 
Baseline NA NA NA NA NA NA NA NA 
Final 6 NA 50 66.7 16.7 16.7 75 100 
DBT 
Baseline NA NA NA NA NA NA NA NA 
Final 6 50 16.7 66.7 16.7 16.7 66.7 66.7 
RAN 
Baseline NA NA NA NA NA NA NA NA 
Final NA NA NA NA NA NA NA NA 
All centres 
combined 
Baseline 26 53.8 76.9 84.6 15.4 0 100 77.8 
Final 24 62.5 50 75 8.7 13 76.9 80 
KEY: NS = Number of slides sampled. GSM = Good sputum smears. GBF = Good blood film. GST = 
Good staining. CON = concordance rate. FP = false positivity rate. SES = Sensitivity. SPE = 
Specificity . NA = not assessed. - Sensitivity and specificity not determined.  
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There was an increase in the specificity of TB 
microscopy reading from all laboratories from 80% at 
the baseline to 97.9% at the final assessment while there 
was a corresponding decrease in sensitivity from 100% 
at the baseline to 77.8% at the final assessment (Table 
3). At the final assessment, 100% specificity was 
achieved for TB microscopy results in four laboratories. 
A specificity of 100% for malaria microscopy was 
maintained in WDL throughout the study, while in IDH 
specificity of malaria microscopy results increased from 
55.6% at baseline to 100% at the final assessment 
(Table 3). 
 
Discussion  
Timely and accurate diagnosis of TB and malaria 
and appropriate treatment are essential for reducing 
disease burden as well as transmission in the 
community [15,16,17]. The cost of implementing 
malaria drug policies based on combination therapy 
could be reduced considerably by improving the 
accuracy of diagnosis, which would target Artemisinin-
based Combination Therapy at those who need it and 
reduce over-consumption of antimalarial drugs by 
patients who do not have malaria [9].  
The WHO has recommended the integration of 
malaria microscopy QA with that of other 
microscopically diagnosed communicable diseases [9], 
but there is no evidence for how this can be put into 
practice. There are no published data about the design 
and implementation of integrated TB-malaria QA 
systems. In this project, a QA for malaria microscopy 
was developed from, and systematically integrated into, 
the existing QA system for TB microscopy. Full or 
partial implementation of the integrated TB-malaria QA 
was achieved in four of the five selected laboratories.  
In this system, TB and malaria microscopy results 
recording, slide storage, monitoring visits to the 
laboratories, LQAS slide sampling, the process of 
rechecking of both by two experienced microscopists, 
results analyses, and feedback mechanisms for 
communicating the performance of individual 
laboratories were combined for malaria and TB 
microscopy. The use of the same microscopists and 
microscopes and the provision of joint training and 
supervision for TB and malaria were feasible at the 
laboratory level.  
The one-day refresher training of microscopists was 
insufficient to demonstrate improvement in their 
individual competency to identify AFB and malaria 
parasites in thin blood film. However, the training and 
integrated QA system may have improved the quality of 
TB and malaria microscopy results from the five 
laboratories, particularly specificity. The average 
specificity of TB microscopy from the five laboratories 
increased from 80% to 97.9%, and for the two 
laboratories undertaking malaria microscopy QA it 
increased from 76.0% and 66.7% to 100%. The average 
specificity of malaria microscopy from the two 
laboratories increased from 77.8% to 80.0%. The TB 
microscopy specificity of 96.8%, 98.9% and 100% were 
reported in Ethiopia [18] Argentina [19] and Tanzania 
[20]. Malaria microscopy specificity of 93.5% - 98.3% 
was observed in ten laboratories on the Thai-Myanmar 
border of Thailand [21].  
On average, the concordance rate of TB microscopy 
results increased from 81% at baseline to 91.0% at the 
final assessment. For malaria microscopy the 
concordance rate increased from 69.2% at the baseline 
to 83.3% at the final assessment in IDH, but decreased 
from 100% to 83.3% in the WDL laboratory due to 
16.7% false positive results. Increases in the concordant 
TB and malaria microscopy results were positively 
associated with the ability of the laboratories to prepare 
and stain sputum smears and blood films for TB and 
malaria microscopy respectively. The concordance rates 
of TB microscopy achieved in Kano were similar to 
those obtained in other developing countries. 
Concordance rates of  ≥ 97% in TB microscopy 
readings were reported in Malawi [22], Argentina [19] 
and southern Ethiopia [18] and 86.2% in malaria in 
South Africa [23].  
The feasibility of integrating the QA system in the 
two laboratories was characterized by good motivation 
and commitment of staff in both laboratories as well as 
clear understanding of the purpose of the quality 
assessment at the start of the project. Laboratories 
where partial integration was achieved showed lack of 
motivation at the start of the project and appeared to 
perceive QA as a threat.  
One of the limitations of the study was that one of 
the five laboratories provided 70% of the slides and 
only two of the five could be fully evaluated for full 
integration. Although the model and the QA monitoring 
team worked well at peripheral laboratory level, scaling 
up this integrated system to cover all laboratories in 
Kano State will be difficult. The laboratories in this 
study may not be truly representative so conclusions 
must be drawn with caution and the model will need 
testing in a variety of situations before generalisations 
can be made.  There are no guidelines in the national or 
state health policy for the development and 
implementation of a malaria microscopy EQA system, 
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so there are no resources or commitment to establish 
malaria QA either as stand-alone or integrated. The 
feasibility of such integration therefore requires a policy 
for its development and implementation at the state 
level. 
Implementing an integrated TB and malaria QA 
scheme at the control programme level requires an 
integrated management system for both TB and malaria 
control programmes, in terms of administrative and 
technical responsibilities. The TB control programme 
had mechanisms to supply reagents and materials to 
these laboratories, so there is a potential for 
incorporating materials needed for malaria microscopy 
into this existing system. A laboratory central 
coordinating unit at the federal level would be helpful 
because it could be the focus of coordination between 
the TB and malaria control programmes and other 
programmes that rely heavily on quality of laboratory 
services. One of the major advantages of this integrated 
system is that it is not dependent on external funding. 
Rather it needs strong management and organization 
using internal resources. One of the big risks is that it 
depends on a well functioning TB QA programme.  
This project demonstrated that it is feasible to 
integrate the training and QA system for TB and 
malaria microscopy and to achieve an improvement in 
the quality of both services. However, the integrated 
system needs to be tested in different settings to develop 
sound recommendations to guide the complex scaling-
up process.  
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